Dosing and uses of Emetrol (phosphorated carbohydrate)
Adult dosage forms and strengths
dextrose/fructose/phosphoric acid
solution, oraL
- 1.87g/1.87g/21.5mg/5mL
Nausea
15-30 mL PO q15min until vomiting stops; not to exceed 5 doses/hr
Pediatric dosage forms and strengths
Nausea
<2 years old: Safety and efficacy not established
2-12 years old: 5-10 ml PO q15min until vomiting stops; not to exceed 5 doses/hr
>12 years old: 15-30 mL PO q15min until vomiting stops; not to exceed 5 doses/hr
Geriatric dosage forms and strengths
Nausea
15-30 mL PO q15min until vomiting stops; not to exceed 5 doses/hr
Emetrol (phosphorated carbohydrate) adverse (side) effects
Frequency not defined
Abdominal pain
Diarrhea
Warnings
Contraindications
Hypersensitivity, diabetes, fructose intolerance
Cautions
Avoid in diabetic patients (carbohydrate content)
Do not ingest fluids at least 15 min after taking product
Pregnancy and lactation
Pregnancy category: NA
Lactation: no studies
Pregnancy categories
A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.
B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.
C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.
D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.
X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.
NA: Information not available.
Pharmacology of Emetrol (phosphorated carbohydrate)
Mechanism of action
Hyperosmolar carbohydrate solution that has a direct effect on the GI tract wall; reduces GI smooth muscle contraction
